期刊文献+

心肌病发病机制的变迁和治疗进展 被引量:5

下载PDF
导出
摘要 心肌病为结构和功能异常的心肌疾病。由于其定义、分类和临床诊断的不确定性,长期临床实践对其病理机制认识不清。最近几十年,诸多方面获得重大进展,如分子和遗传学、病理生理学、以及临床和放射学评价。同时多种心肌病治疗取得进展。对这些疾病的深入认识提示心肌病为一类复杂疾病的总体。本文强调了心肌病分类的演变,目的在于临床医生超越各种分类诊断,诊断更多的特异性心肌病。心肌病基因型的认识改变了病因和临床过程的病理机制理解,在心肌病的临床诊断和预防方面变得越来越重要。基于心肌病的现代分子机制,提供了临床和预后评价的新方法。基因型与表型的复杂方法用于评估,改变了这些疾病的临床评价和治疗。同时阐述了影像学的重要性,尤其超声心动图和心脏核磁共振。总之该文是对心肌病现状的全面综述。
出处 《中国医药科学》 2015年第10期28-34,共7页 China Medicine And Pharmacy
基金 北京市卫生系统高层次卫生技术人才培养项目资助(2009-3-68) 首都医学发展科研基金(2009-3261)
  • 相关文献

参考文献29

  • 1Maron B J, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology Interdisciplinary working groups; and council on epidemiology and prevention[J]. Circulation, 2006, 113 ( 14 ) : 1807-1816.
  • 2Richardson P, McKenna W, Bristow M, et al. Report of the 1995 world health organization/International society and federation of cardiology task force on the definition and classification of cardiomyopathies[J]. Circulation, 1996, 93 ( 5 ) : 841-842.
  • 3Arbustini E, Narula N, Dec GW, et al. The MOGE ( S ) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation[J]. J Am Coil Cardiol, 2013, 62 ( 22 ) : 2046-2072.
  • 4Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy-a heart failure society of America practice guideline[J]. J Card Fail, 2009, 15 ( 2 ) : 83-97.
  • 5Hamayak Sisakian.Cardiomyopathies:Evolution of pathogenesis concepts and potential for new therapies[J].World Journal of Cardiology,2014,6(6):478-494. 被引量:11
  • 6Yoshida A, Ishibashi Ueda H, Yamada N, et al. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure[J]. Eur J Heart Fail, 2013, 15 (2): 166-175.
  • 7Ktlhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myoeardial persistenee of viral genomes and left ventrieular dysfunction[J]. Circulation, 2003, 107 ( 22 ) : 2793- 2798.
  • 8Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT ( PROSPECT ) trial [J]. Circulation, 2008, 117 (20): 2608-2616.
  • 9Suma H, Tanabe H, Uejima T, et al. Selected ventrieuloplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis[J]. Eur J Cardiothorae Surg, 2007, 32 ( 6 ): 912-916.
  • 10Vrtovec B, Poglajen G, Lezaic L, et al. Effects of intracoronary CD34^+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up[J]. Circ Res, 2013, 112 ( 1 ): 165-173.

二级参考文献11

  • 1Eloisa Arbustini,Navneet Narula,G. William Dec,K. Srinath Reddy,Barry Greenberg,Sudhir Kushwaha,Thomas Marwick,Sean Pinney,Riccardo Bellazzi,Valentina Favalli,Christopher Kramer,Robert Roberts,William A. Zoghbi,Robert Bonow,Luigi Tavazzi,Valentin Fuster,Jagat Narula.The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy[J].Journal of the American College of Cardiology.2013(22)
  • 2Bojan Vrtovec,Gregor Poglajen,Luka Lezaic,Matjaz Sever,Dragoslav Domanovic,Peter Cernelc,Aljaz Socan,Sonja Schrepfer,Guillermo Torre-Amione,Fran?ois Haddad,Joseph C. Wu.Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up[J].Circulation Research.2013(1)
  • 3Roman Brenner,Daniel Weilenmann,Micha T. Maeder,Lucas J?rg,Ina Bluzaite,Hans Rickli,Gabriella De Pasquale,Peter Ammann.Clinical Characteristics, Sex Hormones, and Long‐Term Follow‐Up in Swiss Postmenopausal Women Presenting With Takotsubo Cardiomyopathy[J].Clin Cardiol.2012(6)
  • 4Ilan Wittstein.Stress Cardiomyopathy: A Syndrome of Catecholamine-Mediated Myocardial Stunning?[J].Cellular and Molecular Neurobiology.2012(5)
  • 5Samer Arnous,Abdul Mozid,Anthony Mathur.The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design[J].Regen Med.2011(4)
  • 6Bernard J. Gersh,Barry J. Maron,Robert O. Bonow,Joseph A. Dearani,Michael A. Fifer,Mark S. Link,Srihari S. Naidu,Rick A. Nishimura,Steve R. Ommen,Harry Rakowski,Christine E. Seidman,Jeffrey A. Towbin,James E. Udelson,Clyde W. Yancy.2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary[J].Journal of the American College of Cardiology.2011(25)
  • 7H. Cheng,S. Zhao,S. Jiang,M. Lu,C. Yan,J. Ling,Y. Zhang,Q. Liu,N. Ma,G. Yin,J. Wan,Y. Yang,L. Li,R. Jerecic,Z. He.Comparison of cardiac magnetic resonance imaging features of isolated left ventricular non-compaction in adults versus dilated cardiomyopathy in adults[J].Clinical Radiology.2011(9)
  • 8Francesca Girolami,Carolyn Y. Ho,Christopher Semsarian,Massimo Baldi,Melissa L. Will,Katia Baldini,Francesca Torricelli,Laura Yeates,Franco Cecchi,Michael J. Ackerman,Iacopo Olivotto.Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations[J].Journal of the American College of Cardiology.2010(14)
  • 9John Lynn Jefferies,Jeffrey A Towbin.Dilated cardiomyopathy[J].The Lancet.2010(9716)
  • 10Tetsuo Konno,Stephen Chang,Jonathan G Seidman,Christine E Seidman.Genetics of hypertrophic cardiomyopathy[J].Current Opinion in Cardiology.2010(3)

共引文献10

同被引文献24

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部